Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04991714Phase 1Completed
Phase 1, randomised, single-blind trial (4 arms), sponsored by University of Vienna. Primary endpoints: Blood glucose concentration at 120 minutes, Insulin concentration at 120 minutes and 2 more. Started Aug 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04991714.